Skip to main content
Download PDF
Download ePub

Acute coronary syndrome and its treatment outcomes in Ethiopia: a systematic review and meta-analysis

Journal of Pharmaceutical Policy and Practice volume 16, Article number: 98 (2023) Cite this article

Abstract

Background

Acute coronary syndrome (ACS) is the principal cause of death in developing countries including Ethiopia. No study reports the overall patterns of risk factors and burden of in-hospital mortality in Ethiopia. This study, therefore, aimed to assess the magnitude of risk factors, management, and in-hospital mortality of ACS in Ethiopia.

Methods

Electronic searching of articles was conducted using PubMed, Science Direct, EMBASE, Scopus, Hinari, and Google Scholar to access articles conducted in Ethiopia. The Preferred Reporting Items for Systematic Reviews checklist was used for identification, eligibility screening, and selection of articles. Data were extracted with an abstraction form prepared with Microsoft Excel and exported to STATA for analysis. Funnel plot, Begg’s test, and Egger’s test were used to determine publication bias. Heterogeneity between the studies was checked by I2 statistic. The pooled prevalence of risk factors and in-hospital mortality of ACS were estimated using a random-effects meta-analysis model.

Results

Most (59.367%) of the patients had ST-segment elevation myocardial infarction (STEMI). Hypertension (54.814%) was the leading risk factor for ACS followed by diabetes mellitus (38.549%). Aspirin (56.903%) and clopidogrel (55.266%) were most frequently used in patients with STEMI ACS, respectively. The pooled proportion of in-hospital mortality of ACS was 14.82% which was higher in patients with STEMI (16.116%).

Conclusion

The rate of in-hospital mortality is still high which was higher in patients with STEMI. Initiation of treatment must consider the heterogeneity of each patient’s risk factor and reperfusion therapy should be implemented in our setting.

Introduction

Acute coronary syndrome (ACS) is a coronary artery disease caused by narrowing or blockage of the coronary artery lumen, resulting in myocardial ischemia or infarction due to insufficient coronary blood perfusion [1, 2]. ACS, including unstable angina (UA), ST-elevation myocardial infarction (STEMI), and non-ST-elevation myocardial infarction (NSTEMI) is the main cause of cardiovascular death and disability in the world [3, 4]. It is associated with an average of 7.4 million deaths worldwide, 21–22% of all deaths in Europe, and 6–10% of death in sub-Saharan Africa [5, 6].

It is an emergency, life-threatening condition, and financial catastrophe due to high out-of-pocket expenditures for in-hospital care [7, 8]. Even though, there is advancement in diagnosis and management of ACS, still it is the most common cause of death around the globe including in Ethiopia [9, 10]. A study done at Addis Cardiac Hospital, Ethiopia showed that among 300 cardiac patients, 162 (53.7%) of them had ACS [11]. Moreover lower-income countries are facing a double burden of disease because of the higher prevalence of both communicable and non-communicable diseases particularly cardiovascular diseases [10]. These result in frequent hospitalizations, high mortality rate, stretching the already limited resources, and are associated with worse treatment outcomes [9, 12].

Even though ACS is a common health problem with devastating consequences, its burden and risk factors are different according to geographical variation [13, 14]. Previous study in sub-Saharan Africa reported that diabetes, hypertension and cigarette smoking still account for the most common predisposing risk factors [6]. Dyslipidemia, obesity, advanced age, family history of ischemic heart disease and sedentary life style are other most common risk factors reported from different studies [2, 7, 10, 13]. More than 90% of risk factors are potentially modifiable risk factors using pharmacological and non-pharmacological methods. However, it is difficult to achieve these outcomes in resource-limited countries because of insufficient laboratory setup, lack of reperfusion therapy, cost of medications, and discontinuity of care [11, 15, 16]. Though several scholars attempted to describe the extent of risk factors, management and in-hospital mortality due to acute coronary syndrome in Ethiopia, there is no a nationwide study on this area; which is an important research gap. Meta-analysis is a key to improving the accuracy of estimates through the use of more data sets. Therefore, this study was aimed to determine the overall magnitude of risk factors, management, and in-hospital mortality of acute coronary syndrome in Ethiopia.

Materials and methods

Search strategy

This systematic review and meta-analysis were conducted and reported per the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA, 2009) requirements for observational studies [17] (Additional file 1). An electronic search for studies was done by two (BK and MG) of the authors from October 15 to November 30, 2021. PubMed, Science Direct, EMBASE, Cochrane Database, Sci-Hub, Scopus, Africa journal of online library, Hinari, and Google Scholar for free articles were searched. In addition, Addis Ababa, Jimma, and Gondar Universities’ institutional repositories were considered to address unpublished articles in Ethiopia. The searching process was carried out using the full title (“Magnitude of Risk Factors, Management and in Hospital Mortality of Acute coronary syndrome in Ethiopia”) and then keywords (magnitude, risk factors, treatment, mortality, acute coronary syndrome, coronary heart disease, Ethiopia). These different keywords were used individually and in combination using Boolean operators “OR, AND or NOT” as well as medical subject heading [MeSH] terms). In addition, searching reference lists of all the included studies (snowball technique) was done to retrieve other studies that are not addressed by our searching stratagem.

Study selection criteria

All available studies and data were incorporated based on the following predefined eligibility criteria.

Inclusion criteria

  • Study setting and period: All studies conducted in Ethiopia from 2000 to November 30, 2021.

  • Study design: All facility-based observational studies.

  • Study population: Age ≥ 18 years old.

  • Article types: The published and unpublished studies reporting the risk factors of ACS, management, and/or in-hospital mortality.

  • Language: All searches were limited to articles written in the English language.

Exclusion criteria

We excluded reviews and systematic review articles, case reports, and case series. In addition, articles available only in abstract form were excluded because it was difficult to evaluate their quality and extract all necessary information. In the case of duplicates, only the most recent or most complete publication for each data set for a specific outcome was selected.

Outcome variables

The main outcome of this study was the rate of in-hospital mortality. Other secondary outcomes include magnitudes of risk factors and in-hospital management of ACS.

Data extraction

Essential data were extracted from eligible studies by using Microsoft Excel 2019 spreadsheet format. To ensure data quality and methodological validity, two authors (BK and MG) retrieved the data independently. Data were extracted using the PRISMA standard data extraction format. The following information was considered during data extraction: The last name of the first author and year of publication, the region of the study conducted, study design and period, total sample size, sex, types of ACS, risk factors of ACS, the medication used, overall in-hospital mortality and mortality in each type of ACS. Any discrepancies in the data extraction process were solved through discussion involving all authors.

Quality assessment tools

Data extraction was accompanied by two authors independently according to the Critical Appraisal Checklist recommended by the Joanna Briggs Institute (JBI) [18]. The JBI checklist was composed of ten questions, the scores ranged from zero to ten. The studies which obtained more than 60% were considered as good quality studies. None of them had poor quality status and all of them were included in the present inquiry. In addition, the Alberta Heritage Foundation for Medical Research (AHFMR) standard quality assessment criteria for primary research papers was used to check the quality of included articles [19]. Accordingly, the quality of articles was stated as high, moderate and, poor quality with respective scores of ≥ 70%, 51–69%, and ≤ 50%.

Moreover, the disagreements were resolved by consensus and decided by taking the average score of the two reviewers.

Statistical analysis

Data were extracted by using Microsoft excel 2010 format and exported to STATA 14.0 (STATA, College Station, TX, USA) for further analysis. Data were pooled and a random effect meta-analysis with an estimation of DerSimonian and Laird method was applied to determine the pooled prevalence of risk factors, and in-hospital mortality of ACS, and the result was presented using forest plot and odds ratio (OR) with a 95% confident interval (CI), which were used to report the magnitude of the risk factors and mortality in the results of meta-analyses. The pooled prevalence of risk factors and pooled magnitude of in-hospital mortality of ACS were calculated as a weighted average of the individual summary risk factors and a weighted average of the individual summery mortality or ORs), respectively. Similarly, odds ratio of risk factor is simply defined as the ratio of the odds of the risk factor in group (studies) to the odds of the studies without that particular risk factor. Heterogeneity between studies was assessed by computing Chi-square (I2) test statistics. The I2 values of 0, 25, 50, and 75% were considered as no, low, moderate, and high heterogeneities, respectively [20]; unfortunately, in our study, there was high heterogeneity between the original studies (I2 = 95.6%, p < 0.001). Subgroup analysis was considered to examine how medications are used and in hospital, mortality varies across different studies based on types of ACS. Begg’s funnel plot and Egger's regression were used to check publication bias and a p-value less than < 0.05 was considered statically significant. [21]

Results

Characteristics of studies included in the analysis

We identified a total of 271 published and 4 from gray literature through database searches. After duplicate papers were removed and a thorough reading of articles’ abstracts, 24 studies were assessed with the eligibility criteria. Accordingly, 16 irrelevant articles were excluded because they did not qualify the eligibility criteria set. Hence, a total of 8 studies were included in the final analysis as they met the inclusion criteria (Fig. 1). The articles were published between 2013 and 2021; however, there is one unpublished article that was obtained from the Addis Ababa University repository. The result of both Begg’s and Egger’s tests showed that there was considerable publication bias at < 0.001 p-values and < 0.006, respectively, and assessment of publication bias using a funnel plot in (Fig. 2). Most of the studies (6/8, 75%) were cross-sectional studies, others were longitudinal or retrospective follow-up studies.

Fig. 1
figure 1

Flow diagram of literature search and study selection based on Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA)

Full size image
Fig. 2
figure 2

Funnel plot for the publication bias of the included studies for overall all in-hospital mortality

Full size image

More than one-half of the studies were conducted in Addis Ababa city (n = 6) others were conducted in the Oromia region (n = 1), and Tigray region (n = 1). Of a total of 1197 study participants, 813(67.92%) of them were females (Additional file 2). Out of the eight studies included in this review and meta-analyses five studies were single-center [22,23,24,25,26] while the rest three being multi-center. All patients presented with acute coronary syndrome were included in all the eight studies as the number of patients in respective hospitals was limited. Only one study [24] was found to be moderate quality (68.18%) when evaluated with a checklist for assessing the quality of quantitative studies adopted from Kmet and Robert (Additional file 2); whereas, the rest articles had high-quality score.

With regard to diagnostic types of ACS, majority of patients had STEMI (59.367%, 95% CI: 44.558–74.176) followed by NSTEMI (23.365%, 95% CI: 16.559–30.171) and then UA (19.899%, 8.092–31.706) (Table 1).

Table 1 Characteristics of studies included in the meta-analysis
Full size table

Magnitudes of risk factors of ACS in Ethiopia

Patterns of risk factors among ACS patients in selected studies are shown in Table 2 and Additional file 2. Hypertension, diabetes mellitus, and dyslipidemia were the three most prevalent risk factors of ACS in Ethiopia, respectively. A total of 7 studies with 1176 study participants were included to assess the pooled magnitude of hypertension, and diabetes mellitus among ACS patients. Accordingly, our pooled analysis showed that more than one-half (54.814%, 95% CI: 45.158–64.470) of ACS patients had hypertension (Fig. 3). The pooled prevalence of diabetes mellitus in this systematic review and meta-analysis, we found that was 38.549% (95% CI: 26.095–51.004) (Fig. 4). To determine the pattern of dyslipidemia among ACS patients, a total of 2018 participants were included. Consequently, the result showed that nearly one-third of ACS patients (29.108%, 95% CI: 17.612–40.604) had dyslipidemia (Fig. 5).

Table 2 Pooled prevalence of risk factors among ACS patients in Ethiopia
Full size table
Fig. 3
figure 3

Forest plot of the pooled estimate of percentage hypertension among acute coronary syndrome patients in selected studies

Full size image
Fig. 4
figure 4

Forest plot of the pooled estimate of percentage diabetes mellitus among acute coronary syndrome patients in selected studies

Full size image
Fig. 5
figure 5

Forest plot of the pooled estimate of percentage dyslipidemia among acute coronary syndrome patients in selected studies

Full size image

In-hospital management of ACS based on types of ACS in Ethiopia

To determine the medication use pattern, we conducted a subgroup analysis based on diagnostic types of ACS. Anti-platelets, aspirin [56.903% (95% CI: 38.032–75.774)] and clopidogrel [55.266% (95%CI: 35.946–74.58)] were most frequently used in patients with STEMI than NSTEMI and UA. Similarly, more than one-half of patients with STEMI received beta-blockers (BBs) and statins. Primary percutaneous coronary intervention (PCI) was done in 24.558% (95% CI: 3.495–45.621) of patients with STEMI. Patients with UA had most (17.908%) commonly used anti-pain including morphine or fentanyl as compared to patients with NSTEMI (12.009%). Calcium channel blockers were prescribed inpatient with STMEI and UA almost in similar proportion (Additional file 2, Table 3).

Table 3 Subgroup analysis of articles describing medications used based on types of ACS
Full size table

In-hospital mortality of patients with ACS in Ethiopia

In this meta-analysis, we used a total of 1197 ACS patients to determine the overall mortality rate of ACS in Ethiopia. Accordingly, the pooled magnitude of in-hospital mortality of ACS was 14.82% (95% CI: (6.06–23.57) (Fig. 6). Results observed from subgroup analysis showed that in-hospital mortality was greatly varied across different types of ACS. The result indicated that patients with STEMI the highest magnitude of in-hospital mortality was reported in which was 16.156% (95% CI: 9.729–22.503) (Table 4).

Fig. 6
figure 6

Overall all in-hospital mortality among acute coronary syndrome patients in Ethiopia

Full size image
Table 4 Subgroup analysis of studies included on in-hospital mortality by types of ACS
Full size table

Discussion

Currently, ACS is the leading cause of morbidity, mortality, and, high healthcare cost expenditure in resource-limited countries including Ethiopia. Identification of the risk factors of ACS may be important for clinicians and clinical pharmacists to set effective education programs and appropriate initial treatment. This review summarized magnitudes of risk factors, treatment approach, and prevalence of in-hospital mortality among patients with ACS in Ethiopia. Accordingly, the results of this study indicated that hypertension was the most commonly noted risk factor (54.814%) for ACS among included studies. The result was in line with studies conducted in Canada (59.7%), Sweden (58%), Greece (58.8%), and Kenya (55.56) [30,31,32,33].

In contrast, the proportion of hypertension observed in this systematic review and meta-analysis was lower than in studies done in Slovakia (83.5%) and Albania (90.6%) [11, 14]. This variation might be due to lack of diagnostic modalities and proficiency in our setting. On the other hand, a study conducted in Mexico showed that cigarette smoking (69.1%), hypertension (57.8%), and dyslipidemia (47.5%) were the three most prevalent risk factors among patients with ACS [34]. Similarly, a study done in South Africa among Asian Indian patients showed that 82% of ACS patients had visceral obesity as the number one risk factor and 60% of participants were cigarette smokers (60%) [35]. Our findings indicated that the prevalence of smoking and obesity were 19.985%, and 15.663%, respectively. Difference in genetic makeup and lifestyle condition might be the possible cause of variations. Diabetes mellitus and dyslipidemia were also the major risk factors for ACS, accounted 38.549%, and 29.108% of risk factors, respectively. A study conducted in Iran showed that the prevalence of hyperlipidemia was 45.9%, and diabetes mellitus was 31.1% [36]. Similarly a report from Japan, Prevention of Atherothrombotic Incidents Following Ischemic Coronary Attack (PACIFIC) Registry, indicated that dyslipidemia and diabetes mellitus were the main risk factors of ACS, 67.2% and 35.0%, respectively [37]. In addition, many other worldwide studies explained dyslipidemia and diabetes mellitus as common risk factors [15, 31, 32, 34]. These might be because dyslipidemia and diabetes mellitus have co-existed risk profiles and associated structural and functional changes in the cardiovascular system with devastating clinical complications [8, 13].

Pharmacological and invasive procedural therapy including percutaneous coronary intervention (PCI) or fibrinolysis is very essential to decrease in-hospital mortality [15, 30]. The finding of our study revealed that anti-platelets including aspirin and clopidogrel were most frequently used in patients with STEMI than the other two types of ACS, 56.903% and 55.266%, respectively. These were very lower as compared to finding from the Saudi project for assessment of coronary events (SPACE) registry, 98.4%, and 80.1%, respectively [38]. The use of aspirin and clopidogrel were also lower than in studies conducted in Iran (99.4% vs. 98.1%), Brazil (97.6% vs. 88.3%), and Spain (98.0% vs. 97.8%) [36, 39, 40]. This may give insight into the presence of gaps in the use of guideline-directed in-hospital management of ACS in Ethiopia which might be interesting for the future researcher. Different guidelines including the 2020 European Society of Cardiology Clinical Practice Guidelines recommended antiplatelet for all patients with ACS without contraindications, regardless of the type of ACS or the management strategy [41]. Antiplatelet are the cornerstone of ACS management because they significantly reduce the composite outcome of cardiovascular death, myocardial infarction, and stroke. It also considerably lowers the risk of recurrent ischemic events, including stent thrombosis [31, 42].

The use of beta-blockers in STEMI was 51.591% which was lower than studies from Iran (90.9%) and Brazil (80.9%) [36, 39]. The same is true for the use of statins, which was 51.803%. This was also lower than findings from India (84.3%), and Japan (80. 4%) [7, 37]. This variation might be due to differences in access to care, underlying risk factors, costs, and inconstant availability of drugs in Ethiopia. PCI is the most effective reperfusion therapy for symptomatic ACS patients admitted within 90 h [16]. However, only 24.558% of patients with STEMI received PCI therapy. The result was much lower as compared to studies conducted in Poland (55.5%) and Saudi Arabia (42.6%) [9, 38]. Importantly; this result was scored in the absence of using a fibrinolysis agent in Ethiopia. This might be because of problems with PCI service accessibility, limited interventional cardiologists, and delayed admission time to the hospital (range from 4 to 7 days) [22, 28]. Now a day, there are only two PCI-centered public hospitals in Ethiopia [43].

In this review, the overall in-hospital mortality due to ACS was 14.82%. The finding was in line with studies conducted in Pakistan (12.2%), Kenya (17%), and sub-Saharan African countries (10%) [44,45,46]. In contrast, in-hospital mortality found in this study was higher as compared to studies conducted in India (3.9%), China (7.66%), Netherland (3.7%), and Iraq (7.7%) [7, 47,48,49]. The possible causes of variation might be because of delayed initiation of diagnostic and treatment options in our setting. In addition, it might be due to the better availability of reperfusion therapy (PCI, coronary artery bypass graft, and thrombolytic therapy) in those listed countries. Patients with STEMI had higher (16.15%) rate of in-hospital mortality. In contrast, in a study in a central European country, results of the CZECH-2 registry, the rate of mortality was higher in patients with NSTEMI (8.4% for NSTEMI patients, 7.3% for STEMI patients) [50]. The variation might be due to the majority of patients in our study having STEMI (59.367%). The other possible reason for the higher mortality rate in STEMI subtypes of ACS might be the presence of complete blockage of the coronary artery as compared to partial occlusion in NSTEMI and UA.

Limitations of the study

This systematic review and meta-analysis are not free from limitations. The first one is due to the presence of a weak database management system in our country, there may be data not accessible by our search strategy and therefore important measurements, particularly on mortality in each type of ACS might have been missed. In addition, most of the studies done in Ethiopia did not consider the specific name of the medication, dose, and duration of treatment. Due to these, we did not systematically capture data on these key parameters which might have been useful for creating better predictions on in-hospital management of ACS. Moreover, as the study relies on the articles conducted in Ethiopia with variability in study methodologies, the pooled prevalence estimates and conclusions may not be generalized to the rest of the world.

Time to present at a health institution after the onset of signs and symptoms is also a matter which is not addressed by this review. Finally, data were obtained from articles conducted with different methodologies and geographical regions; these may have an impact on the variation in magnitude of risk factors and practice in hospital management. Finally, both published and unpublished articles were included with different methodologies and geographical regions; these may have an impact on the variation in magnitude of risk factors and practice in hospital management.

However, this review provides useful information about the patterns of risk factors that contributed to the development of ACS. Besides, the review provides insight into the burden of ACS-associated mortality at the national level to help policymakers to design cost-effective plans and treatment strategies to combat the ACS burden and improve treatment outcomes.

Conclusion

ACS is a major public health problem in Ethiopia with diverse clinical risk factors. Hypertension was the leading risk factor noted for ACS followed by diabetes mellitus and dyslipidemia. The use of guideline-directed in-hospital management was not comparable to that of registries from different countries in the world. Even though few patients were managed by PCI, we may conclude that the reperfusion therapy rate was almost zero in the absence of a fibrinolysis agent. The rate of in-hospital mortality among ACS patients is still high and the risk of death was higher in patients with STEMI. Initiation of treatment in clinical practice must take into account the heterogeneity of each patient’s risk factor. Health-related policymakers should work on the wide accessibility for the advanced therapies of PCI and thrombolytic following the patients’ socioeconomic status, which ultimately may help improve favorable patients’ in-hospital outcomes.

Availability of data and materials

Additional data are supplied as additional material.

Code availability

Not applicable.

References

  1. Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015;28(2):283–93.

    PubMed  Google Scholar 

  2. Guo JJ, Chen Y, Du W, Peng H, Wang R, Xia Y, Xin P, Wigle PR, Papadimitropoulos EA. Antithrombotic therapy and direct medical costs in patients with acute coronary syndrome in Shanghai China. Value Health Regional Issues. 2016;1(9):93–8.

    CAS  Google Scholar 

  3. Shehab A, Al-Dabbagh B, AlHabib KF, Alsheikh-Ali AA, Almahmeed W, Sulaiman K, Al-Motarreb A, Nagelkerke N, Suwaidi JA, Hersi A, Faleh HA. Gender disparities in the presentation, management, and outcomes of acute coronary syndrome patients: data from the 2nd Gulf Registry of Acute Coronary Events (Gulf RACE-2). PLoS ONE. 2013;8(2):e55508.

    PubMed  PubMed Central  CAS  Google Scholar 

  4. Zhang H, Goodman SG, Yan RT, Steg PG, Kornder JM, Gyenes GT, Grondin FR, Brieger D, DeYoung JP, Gallo R, Yan AT. In-hospital management and outcomes of acute coronary syndromes in relation to prior history of heart failure. Eur Heart J Acute Cardiovasc Care. 2016;5(3):214–22.

    PubMed  Google Scholar 

  5. Rayner M, Petersen S. European cardiovascular disease statistics 2000 edition. British Heart Foundation. 2000;14–35.

  6. Shavadia J, Yonga G, Otieno H. A prospective review of acute coronary syndromes in an urban hospital in sub-Saharan Africa: cardiovascular topics. Cardiovasc J Afr. 2012;23(6):318–21.

    PubMed  PubMed Central  Google Scholar 

  7. Mohanan PP, Mathew R, Harikrishnan S, Krishnan MN, Zachariah G, Joseph J, Eapen K, Abraham M, Menon J, Thomas M, Jacob S. Presentation, management, and outcomes of 25 748 acute coronary syndrome admissions in Kerala, India: results from the Kerala ACS Registry. Eur Heart J. 2013;34(2):121–9.

    PubMed  Google Scholar 

  8. Zubaid M, Rashed WA, Al-Khaja N, Almahmeed W, Al-Lawati J, Sulaiman K, AlMotarreb A, Amin H, Al-Suwaidi J, Al-Habib K. Clinical presentation and outcomes of acute coronary syndromes in the gulf registry of acute coronary events (Gulf RACE). Saudi Med J. 2008;29(2):25–34.

    Google Scholar 

  9. Poloński L, Gąsior M, Gierlotka M, Kalarus Z, Cieśliński A, Dubiel JS, Gil RJ, Rużyłło W, Trusz-Gluza M, Zembala M, Opolski G. Original article Polish Registry of Acute Coronary Syndromes (PL-ACS) Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland. Kardiologia Polska (Polish Heart Journal). 2007;65(8):861–72.

    PubMed  Google Scholar 

  10. Shashu BA, Ayele MA. The pattern of coronary artery diseases as diagnosed by coronary angiography and the outcome of Percutaneous Coronary Intervention (PCI) in Ethiopia. Ethiop J Heal Dev. 2014;28(1):12–6.

    Google Scholar 

  11. Simoni L, Alimehmeti I, Ceka A, Tafaj E, Gina M, Dibra A, Goda A. Admissions and in hospital outcomes of acute coronary syndromes during corona virus disease 19 pandemic in Albania. Open Access Macedonian J Med Sci. 2021;9(1):593–9.

    Google Scholar 

  12. Tolla MT, Norheim OF, Verguet S, Bekele A, Amenu K, Abdisa SG, Johansson KA. Outof-pocket expenditures for prevention and treatment of cardiovascular disease in general and specialized cardiac hospitals in Addis Ababa, Ethiopia: a cross-sectional cohort study. BMJ Glob Health. 2017;2(2):1–4.

    Google Scholar 

  13. Smith FG, Brogan RA, Alabas O, Laut KG, Quinn T, Bugiardini R, Gale CP. Comparative care and outcomes for acute coronary syndromes in Central and Eastern European Transitional countries: a review of the literature. Eur Heart J Acute Cardiovasc Care. 2015;4(6):537–54.

    PubMed  Google Scholar 

  14. Alberty R, Studenčan M, Kovář F. Prevalence of conventional cardiovascular risk factors in patients with acute coronary syndromes in Slovakia. Cent Eur J Public Health. 2017;25(1):77–84.

    PubMed  Google Scholar 

  15. Raposeiras-Roubín S, Abu-Assi E, Cabanas-Grandío P, Agra-Bermejo RM, Gestal-Romarí S, Pereira-López E, Fandiño-Vaquero R, Álvarez-Álvarez B, Cambeiro C, Rodríguez-Cordero M, Lear P. Walking beyond the GRACE (global registry of acute coronary events) model in the death risk stratification during hospitalization in patients with acute coronary syndrome. Cardiovasc Intervent. 2012;5(11):1117–25.

    Google Scholar 

  16. Shashu BA. The management of coronary artery disease in Ethiopia: emphasis on revascularization. Ethiop J Health Sci. 2021;31(2).

  17. Moher A, Liberati J, Tetzlaff A. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Internal Med. 2009;151(4):264–9.

    Google Scholar 

  18. Peters M, Godfrey C, McInerney P, Soares C, Khalil H, Parker D. The Joanna Briggs Institute reviewers’ manual 2015: a methodology for JBI scoping reviews.

  19. Kmet LM, Cook LS, Lee RC. Standard quality assessment criteria for evaluating primary research papers from a variety of fields.

  20. Rücker G, Schwarzer G, Carpenter JR, Schumacher M. Undue reliance on I2 in assessing heterogeneity may mislead. BMC Med Res Methodol. 2008;8(1):1–9.

    Google Scholar 

  21. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1(2):97–111.

    PubMed  Google Scholar 

  22. Desta DM, Nedi T, Hailu A, Atey TM, Tsadik AG, Asgedom SW, Kasahun GG, Ayalew E. Treatment outcome of acute coronary syndrome patients admitted to Ayder Comprehensive Specialized Hospital, Mekelle, Ethiopia. A retrospective cross-sectional study. PLoS ONE. 2020;15(2):1–17.

    Google Scholar 

  23. Bogale K, Mekonnen D, Nedi T, Woldu MA. Treatment outcomes of patients with acute coronary syndrome admitted to Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Clin Med Insights Cardiol. 2019;13:1–9.

    Google Scholar 

  24. Tsegaye T, Gishu T, Habte MH, Bitew ZW. Recovery rate and predictors among patients with acute coronary syndrome in Addis Ababa, Ethiopia: a retrospective cohort study. Res Reports Clin Cardiol. 2021;30(12):9–21.

    Google Scholar 

  25. Tilahun H, Yadeta D, Roth G. Pattern, management and outcome of the acute coronary syndrome in an urban hospital in Ethiopia. J Am Coll Cardiol. 2020;75(11):3507–8.

    Google Scholar 

  26. Fanta K, Daba FB, Asefa ET, Melaku T, Chelkeba L, Fekadu G, Gudina EK. Management and 30-day mortality of acute coronary syndrome in a resource-limited setting: insight from Ethiopia. A prospective cohort study. Front Cardiovasc Med. 2021;8:1–7.

    Google Scholar 

  27. Giday A, Weldeyes E, O’Mara J. Characteristics and management of patients with acute coronary syndrome at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. Ethiop Med J. 2013;51(4):269–72.

    PubMed  Google Scholar 

  28. Wakwaya R. Clinical features and outcome of acute coronary syndrome in patients presenting to the emergency department in Addis Ababa, Ethiopia. Austin J Cardiovasc Dis Atherosclerosis. 2019;6(1):2472–3568.

    Google Scholar 

  29. Mebrahatom G, Debebe F, Zewdu T. Assessment of clinical profile and outcome of patients with the acute coronary syndrome in Tikur Anbessa and Aabet Hospitals, Addis Abeba, Ethiopia. 2018;15–22

  30. Wang JY, Goodman SG, Saltzman I, Wong GC, Huynh T, Dery JP, Leiter LA, Bhatt DL, Welsh RC, Spencer FA, Fox KA. Cardiovascular risk factors and in-hospital mortality in acute coronary syndromes: insights from the Canadian global registry of acute coronary events. Can J Cardiol. 2015;31(12):1455–61.

    PubMed  Google Scholar 

  31. Rosengren A, Wallentin L, Simoons M, Gitt AK, Behar S, Battler A, Hasdai D. Cardiovascular risk factors and clinical presentation in acute coronary syndromes. Heart. 2005;91(9):1141–7.

    PubMed  PubMed Central  CAS  Google Scholar 

  32. Andrikopoulos G, Terentes-Printzios D, Tzeis S, Vlachopoulos C, Varounis C, Nikas N, Lekakis J, Stakos D, Lymperi S, Symeonidis D, Chrissos D. Epidemiological characteristics, management and early outcomes of acute coronary syndromes in Greece: the PHAETHON study. Hellenic J Cardiol. 2016;57(3):157–66.

    PubMed  CAS  Google Scholar 

  33. Wachira BW, Owuor AO, Otieno HA. Acute management of ST-elevation myocardial infarction in a tertiary hospital in Kenya: Are we complying with practice guidelines? Afr J Emerg Med. 2014;4(3):104–8.

    Google Scholar 

  34. González-Pacheco H, Vargas-Barrón J, Vallejo M, Piña-Reyna Y, Altamirano-Castillo A, Sánchez-Tapia P, Martínez-Sánchez C. Prevalence of conventional risk factors and lipid profiles in patients with acute coronary syndrome and significant coronary disease. Ther Clin Risk Manag. 2014;10:815–21.

    PubMed  PubMed Central  Google Scholar 

  35. Ranjith N, Pegoraro RJ, Zaahl MG. Risk factors associated with acute coronary syndromes in South African Asian Indian patients (The AIR Study). J Clin Exp Cardiol. 2011;2(163):2–8.

    Google Scholar 

  36. Kassaian SE, Masoudkabir F, Sezavar H, Mohammadi M, Pourmoghaddas A, Kojouri J, Ghaffari S, Sanaati H, Alaeddini F, Pourmirza B, Mir E. Clinical characteristics, management and 1-year outcomes of patients with the acute coronary syndrome in Iran: the Iranian Project for Assessment of Coronary Events 2 (IPACE2). BMJ Open. 2015;5(12):1–13.

    Google Scholar 

  37. Daida H, Miyauchi K, Ogawa H, Yokoi H, Matsumoto M, Kitakaze M, Kimura T, Matsubara T, Ikari Y, Kimura K, Tsukahara K. Management and two-year long-term clinical outcome of acute coronary syndrome in Japan-Prevention of AtherothrombotiC Incidents Following Ischemic Coronary Attack (PACIFIC) Registry. Circ J. 2013;77(4):934.

    PubMed  CAS  Google Scholar 

  38. AlHabib KF, Hersi A, AlFaleh H, AlNemer K, AlSaif S, Taraben A, Kashour T, Bakheet A, Al Qarni A, Soomro T, Malik A. Baseline characteristics, management practices, and in-hospital outcomes of patients with acute coronary syndromes: results of the Saudi project for assessment of coronary events (SPACE) registry. J Saudi Heart Assoc. 2011;23(4):233–9.

    PubMed  PubMed Central  Google Scholar 

  39. Mattos LA, Berwanger O, Santos ES, Reis HJ, Romano ER, Petriz JL, Sousa AC, Neuenschwander FC, Guimarães JI, Andrade JP. Clinical outcomes at 30 days in the Brazilian Registry of Acute Coronary Syndromes (ACCEPT). Arq Bras Cardiol. 2013;100:6–13.

    Google Scholar 

  40. Barrabés JA, Bardají A, Jiménez-Candil J, del Nogal SF, Bodí V, Basterra N, Marco E, Melgares R, de la Hoz JC, Fernández-Ortiz A. Prognosis and management of acute coronary syndrome in Spain in 2012: the DIOCLES study. Revista Española de Cardiología (English Edition). 2015;68(2):98–106.

    Google Scholar 

  41. Nadarajah R, Gale C. The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: key points from the ESC 2020 Clinical Practice Guidelines for the general and emergency physician. Clin Med. 2021;21(2):206–9.

    Google Scholar 

  42. Galli M, Andreotti F, D’Amario D, Vergallo R, Vescovo GM, Giraldi L, Migliaro S, Ameri P, Porto I, Crea F. Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2020;6(1):43–56.

    PubMed  Google Scholar 

  43. Leuner CJ, Weldegerima AH. Cardiology services in Ethiopia. Eur Heart J. 2018;39:2699–700.

    PubMed  Google Scholar 

  44. Firdous S, Mehmood MA, Malik U. Validity of GRACE risk score as a prognostic marker of in-hospital mortality after acute coronary syndrome. J College Phys Surg Pak JCPSP. 2017;27(10):597–601.

    Google Scholar 

  45. Bahiru E, Temu T, Gitura B, Farquhar C, Huffman MD, Bukachi F. Presentation, management and outcomes of the acute coronary syndrome: a registry study from Kenyatta National Hospital in Nairobi Kenya. Cardiovasc J Afr. 2018;29(4):225–30.

    PubMed  Google Scholar 

  46. N’Guetta R, Yao H, Ekou A, N’Cho-Mottoh MP, Angoran I, Tano M, Konin C, Coulibaly I, Anzouan-Kacou JB, Seka R, Adoh AM. Prevalence and characteristics of acute coronary syndromes in a sub-Saharan Africa population. Annales de cardiologie et d’angeiologie. 2016;65(2):59–63.

    PubMed  CAS  Google Scholar 

  47. Wang Y, Fu R, Wang Z, Bao H, Chen Y, Yang F, Luo X, Liu M. Assessing the quality of care for patients with acute myocardial infarction in China. Clin Cardiol. 2015;38(6):327–32.

    PubMed  PubMed Central  Google Scholar 

  48. Hoedemaker NP, de Winter RJ, van’t Hof A, Kolkman E, Damman P. Optimal medical therapy prescription in patients with acute coronary syndrome in the Netherlands: a multicenter pilot registry. Am J Cardiovasc Drugs. 2021;21(2):219–29.

    PubMed  CAS  Google Scholar 

  49. Hamid MB. Clinical characteristics and outcomes of acute coronary syndromes in a group of Iraqi Patients. Iraqi J Med Sci. 2016;14(4):304–9.

    Google Scholar 

  50. Tousek P, Tousek F, Horak D, Cervinka P, Rokyta R, Pesl L, Jarkovsky J, Widimsky P, CZECH-2 Investigators. The incidence and outcomes of acute coronary syndromes in a central European country: results of the CZECH-2 registry. Int J Cardiol. 2014;173(2):204–8.

    PubMed  Google Scholar 

Download references

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Pharmacy Department, Health Science College, Debre Markos University, Debre Markos, Ethiopia

    Bekalu Kebede, Melese Getachew, Samuel Agegnew, Ephrem Mebratu Dagnew, Dehnnet Abebe, Anteneh Belayneh, Bantayehu Addis Tegegne & Mekides Kiflu

  2. Department of Nursing, Health Science College, Debre Markos University, Debre Markos, Ethiopia

    Tiringo Kebede

  3. Department of Pediatrics and Child Health Nursing, Health Science College, Debre Markos University, Debre Markos, Ethiopia

    Yalemgeta Biyazin

  4. Department of Biomedical Sciences, School of Medicine, Debre Markos University, Debre Markos, Ethiopia

    Yoseph Merkeb Alamneh

Authors
  1. Bekalu Kebede
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Melese Getachew
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samuel Agegnew
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ephrem Mebratu Dagnew
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dehnnet Abebe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anteneh Belayneh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bantayehu Addis Tegegne
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tiringo Kebede
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Mekides Kiflu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yalemgeta Biyazin
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Yoseph Merkeb Alamneh
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors made substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; took part in drafting the article or revising it critically for important intellectual content; agreed to submit it to the current journal; gave final approval of the version to be published; and agree to be accountable for all aspects of the work.

Corresponding author

Correspondence to Melese Getachew.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors agree to submit this manuscript to journal of SN Comprehensive Clinical Medicine.

Competing interests

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1:

PRISMA checklist summarizing the quality of articles included.

Additional file 2:

Magnitudes of risk factors among Acute coronary syndrome in Ethiopia.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kebede, B., Getachew, M., Agegnew, S. et al. Acute coronary syndrome and its treatment outcomes in Ethiopia: a systematic review and meta-analysis. J of Pharm Policy and Pract 16, 98 (2023). https://doi.org/10.1186/s40545-023-00603-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40545-023-00603-7

Keywords

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us